𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of 18F-fluorodeoxyglucose–positron emission tomography in the assessment of disease activity in patients with Takayasu arteritis

✍ Scribed by Kwang-Hoon Lee; Arthur Cho; Yun-Jung Choi; Sang-Won Lee; You-Jung Ha; Se-Jin Jung; Min-Chan Park; Jong-Doo Lee; Soo-Kon Lee; Yong-Beom Park

Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
108 KB
Volume
64
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is 18F-fluorodeoxyglucose positron emiss
Is 18F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in takayasu arteritis?
✍ Laurent Arnaud; Julien Haroche; Zoulikha Malek; Frédérique Archambaud; Laetitia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB

## Abstract ## Objective ^18^F‐fluorodeoxyglucose–positron emission tomography (FDG‐PET) scanning has been proposed as a new way of assessing disease activity in Takayasu arteritis (TA), but previous studies have used the nonvalidated National Institutes of Health (NIH) global activity criteria, a

18F-fluorodeoxyglucose–positron emission
18F-fluorodeoxyglucose–positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease
✍ Laurent Arnaud; Zoulikha Malek; Frédérique Archambaud; Aurélie Kas; Dan Toledano 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

## Abstract ## Objective Erdheim‐Chester disease (ECD) is a rare form of non–Langerhans' cell histiocytosis. The aim of this study was to assess the value of whole‐body scanning with ^18^F‐fluorodeoxyglucose–positron emission tomography (FDG‐PET) in a large cohort of ECD patients from a single cen